NCT00659698

Effect of an Artificial Pancreas in Patients Undergoing Hepatic Resection

Prevention for Surgical Site Infection After Hepatic Resection

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Kochi University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study evaluated that strict control of perioperative blood glucose following hepatic resection by using an artificial pancreas would improve postoperative surgical site infection.

Detailed description

This study recruited 70 patients undergoing elective hepatic resection for liver diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system. We prospectively divided patients into two groups: one for whom glucose levels were controlled using a manual injection of insulin according to the commonly used sliding scale and another that received programmed infusions of insulin determined by the control algorithm of the artificial pancreas.

Conditions

• Liver Diseases

Interventions

Type	Name	Description
DEVICE	the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)	artificial pancreas

Timeline

• Start date: 2007-04-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2008-04-16
• Last updated: 2008-04-16

Locations

1 site across 1 country: Japan